Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials

The association between glucagon-like peptide-1 (GLP-1) receptor agonists and the risk of various kinds of thyroid disorders remains uncertain. We aimed to evaluate the relationship between the use of GLP-1 receptor agonists and the occurrence of 6 kinds of thyroid disorders. We searched PubMed (MED...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Weiting, Song, Rui, Cheng, Rui, Liu, Caihong, Guo, Rui, Tang, Wei, Zhang, Jie, Zhao, Qian, Li, Xing, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309474/
https://www.ncbi.nlm.nih.gov/pubmed/35898463
http://dx.doi.org/10.3389/fendo.2022.927859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309474/
https://www.ncbi.nlm.nih.gov/pubmed/35898463
http://dx.doi.org/10.3389/fendo.2022.927859

Ejemplares similares